James Herriott - 30 Dec 2022 Form 3 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
General Counsel
Signature
/s/ James Herriott by Mark R. Busch, attorney-in-fact
Issuer symbol
EXAS
Transactions as of
30 Dec 2022
Net transactions value
$0
Form type
3
Filing time
30 Dec 2022, 15:21:10 UTC
Next filing
16 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EXAS Common Stock 8,612 30 Dec 2022 Direct
holding EXAS Common Stock 613 30 Dec 2022 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EXAS Restricted Stock Units 30 Dec 2022 Common Stock 960 Direct F1, F2
holding EXAS Restricted Stock Units 30 Dec 2022 Common Stock 3,531 Direct F2, F3
holding EXAS Restricted Stock Units 30 Dec 2022 Common Stock 3,458 Direct F2, F4
holding EXAS Restricted Stock Units 30 Dec 2022 Common Stock 6,590 Direct F2, F5
holding EXAS Stock Option (right to buy) 30 Dec 2022 Common Stock 793 $92.62 Direct F6
holding EXAS Stock Option (right to buy) 30 Dec 2022 Common Stock 2,861 $98.18 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit award that vests in full on February 26, 2023.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 Represents a restricted stock unit award that vests in two equal annual installments beginning on February 14, 2023.
F4 Represents a restricted stock unit award that vests in three equal annual installments beginning on February 19, 2023.
F5 Represents a restricted stock unit award that vests in four equal annual installments beginning on February 25, 2023.
F6 These options vest and become exercisable in full on February 26, 2023.
F7 These options vest and become exercisable in two equal annual installments beginning on February 14, 2023.